Trinity Biotech News (NASDAQ:TRIB)

DateTimeSource
Headline
10/31/20163:24PMPRNUSSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Trinity...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Trinity Biotech plc and Certain Officers and Directors -- TRIB PR Newswire NEW YORK, Oct. 31, 2016 NEW YORK, Oct. 31, 2016 /PRNewswire/ -- Levi & Korsinsky, LLP announces that it has commenced an... More...>>
10/25/20168:15AMGLOBETrinity Biotech announces Quarter 3 Financial Results
DUBLIN, Ireland, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2016. Quarter 3 Results                                                                                          ... More...>>
10/19/201612:17PMBWIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Trinity Biotech plc & Advises Investors with Losses ...
Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against Trinity Biotech plc (“Trinity” or the “Company”) (Nasdaq: TRIB) concerning possible violations of federal securities laws. To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law... More...>>
10/12/201610:22AMGLOBETrinity Biotech plc to Announce Third Quarter Fiscal Year 2016 Financial Results
DUBLIN, Ireland, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2016 on Tuesday, October 25, 2016. The Company has scheduled... More...>>
10/06/20166:59PMBWIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Trinity Biotech plc & Encourages Investors with ...
Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Trinity Biotech plc (“Trinity” or the “Company”) (Nasdaq: TRIB) concerning possible violations of federal securities laws. If you purchased shares of Trinity and want more information, please contact Joon M. Khang, Esquire... More...>>
10/06/20165:24PMBWINVESTOR ALERT: Investigation of Trinity Biotech plc Announced by Law Offices of Howard G. Smith
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Trinity Biotech plc (“Trinity” or the “Company”) (NASDAQ: TRIB) concerning the Company and its officers’ possible violations of federal securities laws. Trinity acquires, develops, manufactures and markets medical diagnostic... More...>>
10/05/20167:19PMBWINVESTOR ALERT: Goldberg Law PC Announces an Investigation of Trinity Biotech plc & Advises Investors with Losses to Contact ...
Goldberg Law PC announces that it is investigating Trinity Biotech plc (“Trinity” or the “Company”) (Nasdaq: TRIB) concerning possible violations of federal securities laws. If you purchased or otherwise acquired Trinity shares and would like more information regarding the investigation, we advise you to contact... More...>>
10/05/20165:55PMPRNUSTRINITY NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Trinit...
TRINITY NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Trinity Biotech plc To Contact The Firm PR Newswire NEW YORK, Oct. 5, 2016 NEW YORK, Oct. 5, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating... More...>>
10/05/20165:04PMBWSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Trinity...
Levi & Korsinsky, LLP announces that it has commenced an investigation of Trinity Biotech plc (“Trinity” or the “Company”) (NASDAQ:TRIB) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On October 4, 2016, Trinity revealed that it was withdrawing... More...>>
10/05/20161:28PMBWIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Trinity Biotech plc & Advises Investors with Losses to ...
Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against Trinity Biotech plc (“Trinity” or the “Company”) (Nasdaq: TRIB) concerning possible violations of federal securities laws. To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law... More...>>
10/05/201612:55PMPRNUSSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB) PR Newswire NEW YORK, Oct. 5, 2016 NEW YORK, Oct. 5, 2016 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Trinity Biotech... More...>>
10/05/201612:00PMPRNUSSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trinity Biotech plc - TRIB
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trinity Biotech plc - TRIB PR Newswire NEW YORK, Oct. 5, 2016 NEW YORK, Oct. 5, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB) (ISIN:... More...>>
10/04/20168:30AMGLOBETrinity Biotech Announces withdrawal of Troponin FDA 510(k) Submission
DUBLIN, Ireland, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced today that it is withdrawing its 510(k) premarket notification submission for the Meritas Troponin-I Test and... More...>>
07/21/20168:22AMGLOBETrinity Biotech Announces Quarter 2 Financial Results
DUBLIN, Ireland, July 21, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2016. Quarter 2 Results Total revenues for Q2, 2016 were $26.3m... More...>>
07/14/20166:06AMGLOBETrinity Biotech plc to Announce Second Quarter Fiscal Year 2016 Financial Results
DUBLIN, Ireland, July 14, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2016 on Thursday, July 21, 2016. The Company has scheduled... More...>>
05/09/20169:49AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Monday's session are LendingClub Corp. (LC), Krispy Kreme Doughnuts Inc. (KKD), and Freeport-McMoRan Inc. (FCX). LendingClub on Monday said Renaud Laplanche resigned as chief executive and chairman following an internal review of sales of $22 million in... More...>>
04/19/20168:30AMGLOBETrinity Biotech Announces Results for Q1, 2016
DUBLIN, April 19, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2016. Quarter 1 Results Total revenues for Q1, 2016 were $23.5m which compares... More...>>
04/15/20166:57AMGLOBETrinity Biotech plc to Announce First Quarter Fiscal Year 2016 Financial Results
DUBLIN, April 15, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2016 on Tuesday, April 19, 2016. The Company has scheduled a conference... More...>>
03/09/20167:46PMGLOBETrinity Biotech Announces Results for Q4 and Fiscal Year 2015
DUBLIN, March 03, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2015 and the quarter ended December 31, 2015. The Company also announced that it is suspending... More...>>
03/09/20167:46PMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2015 Financial Results
DUBLIN , Feb. 26, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2015 on Thursday, March 3, 2016. The Company has scheduled... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20161205 08:26:16